CRDF Cardiff Oncology, Inc.
8-K Current Report
Filed: February 24, 2026
Health Care
Biological Products, (No Diagnostic Substances)Cardiff Oncology, Inc. (CRDF) 8-K current report filed with SEC EDGAR on February 24, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.
Reported 8-K Items1 item
- Item 2.02: Results of Operations and Financial Condition
AI Filing Analysis8-K
Item 2.02 · Results of Operations and Financial Condition
- • Full-year 2025 financial results disclosed via press release (Exhibit 99.1)
- • Reporting period: fiscal year ended December 31, 2025
Other Cardiff Oncology, Inc. 8-K Filings
Get deeper insights on Cardiff Oncology, Inc.
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.